Kuwait Life Sciences Company

Kuwait Life Sciences Company (KLSC) is a fully owned subsidiary of National Technology Enterprises Company (NTEC), which is itself owned by the Kuwait Investment Authority. Established in 2010, KLSC operates as a pioneer venture capitalist and private equity company in the Middle East, focusing on healthcare investment, life sciences training, medical technology, and pharmaceutical distribution.

KLSC targets the Middle East and North Africa (MENA) region to address unmet healthcare needs. The company aims to be the Middle East's premiere Life Sciences Company by investing in best-in-class healthcare companies and transferring their technology into the region.

The company is fully owned by National Technology Enterprises Company (NTEC). NTEC was incorporated in November 2002 by the Kuwait Council of Ministers and is capitalized at 100 million Kuwait Dinars, making it a sovereign wealth-backed entity.

KLSC provides healthcare investment, life sciences training, medical technology solutions, and pharmaceutical distribution. They also support public and private sector stakeholders in accessing emerging technologies and establishing unique healthcare projects.

Through its training arm, LSA, KLSC collaborates with international top-ranked medical universities to provide accredited, state-of-the-art training programs. They also work with regional and local experts to share the latest practices in the field.

KLSC's mission is to invest in proven life sciences and healthcare companies to transfer their technology into the Middle East via strategic platforms. They also aim to champion foundational gateways for global investment opportunities into the region.

Reviewers frequently praise the company's website for being very informative, easy to navigate, and user-friendly. Many also highlight the exceptional quality of the services provided and the helpfulness of the customer service team.

The Trustburn rating is 4.5 out of 5 stars based on 8 reviews. The most recent review was posted on September 11, 2023, while the oldest visible review in the list dates back to January 23, 2023.

KLSC was established with a paid-up capital of 15 million Kuwait Dinars (approximately $53 million USD). Its parent company, NTEC, is capitalized at 100 million Kuwait Dinars (approximately $350 million USD).

KLSC aims to achieve superior returns from innovative regional operations and global investments. Their vision is to become the Middle East's premiere Life Sciences Company through integrated healthcare projects and unique ventures.

The company embraces entrepreneurship as an essential component for growing the nascent Middle East Life Sciences and Healthcare industry. They view it as a vital pillar of a Knowledge Economy to advance healthcare systems within the region.

KLSC mentions prestigious affiliations with international top-ranked medical universities to deliver state-of-the-art training programs. These programs are designed to transform healthcare leaders and inspire system-wide change.

LSA aims to develop healthcare professionals' knowledge, practice, and clinical outcomes. The platform focuses on transforming healthcare leaders to advance the system and inspire positive change through continuous professional development.

KLSC operates globally but focuses its regional operations and investments on the Middle East and North Africa (MENA) region. They seek to adapt best practices prevailing in today's healthcare field to this specific area.